Question · asked by 1 review

Transarterial embolisation plus radiofrequency ablation vs radiofrequency ablation: Serious adverse events (number of participants)

It is very uncertain whether transarterial embolisation plus radiofrequency ablation changes serious adverse events (number of participants) compared with radiofrequency ablation (very low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Transarterial embolisation plus radiofrequency ablation vs radiofrequency ablation
Serious adverse events (number of participants) · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
It is very uncertain whether transarterial embolisation plus radiofrequency ablation changes serious adverse events (number of participants) compared with radiofrequency ablation (very low certainty).
Management of people with early‐ or very early‐stage hepatocellular carcinoma (2017) · Cochrane Headline outcomes only
OR 2.11 [0.18, 25.35]2 studies · 84 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Management of people with early‐ or very early‐stage hepatocellular carcinoma
2017 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.